Gary W. Arendash - Publications

University of South Florida, Tampa, FL, United States 
Neuroscience Biology

113 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Citron BA, Saykally JN, Cao C, Dennis JS, Runfeldt M, Arendash GW. Transcription factor Sp1 inhibition, memory, and cytokines in a mouse model of Alzheimer's disease. American Journal of Neurodegenerative Disease. 4: 40-8. PMID 26807343  0.36
2015 Citron BA, Saykally JN, Cao C, Dennis JS, Runfeldt M, Arendash GW. Transcription factor Sp1 inhibition, memory, and cytokines in a mouse model of alzheimer’s disease American Journal of Neurodegenerative Diseases. 4: 40-48.  0.36
2013 Tajiri N, Kellogg SL, Shimizu T, Arendash GW, Borlongan CV. Traumatic brain injury precipitates cognitive impairment and extracellular Aβ aggregation in Alzheimer's disease transgenic mice. Plos One. 8: e78851. PMID 24223856 DOI: 10.1371/Journal.Pone.0078851  0.44
2012 Dragicevic N, Delic V, Cao C, Copes N, Lin X, Mamcarz M, Wang L, Arendash GW, Bradshaw PC. Caffeine increases mitochondrial function and blocks melatonin signaling to mitochondria in Alzheimer's mice and cells. Neuropharmacology. 63: 1368-79. PMID 22959965 DOI: 10.1016/J.Neuropharm.2012.08.018  0.44
2012 Arendash GW. Transcranial electromagnetic treatment against Alzheimer's disease: why it has the potential to trump Alzheimer's disease drug development. Journal of Alzheimer's Disease : Jad. 32: 243-66. PMID 22810103 DOI: 10.3233/Jad-2012-120943  0.44
2012 Arendash GW, Mori T, Dorsey M, Gonzalez R, Tajiri N, Borlongan C. Electromagnetic treatment to old Alzheimer's mice reverses β-amyloid deposition, modifies cerebral blood flow, and provides selected cognitive benefit. Plos One. 7: e35751. PMID 22558216 DOI: 10.1371/Journal.Pone.0035751  0.44
2012 Cao C, Loewenstein DA, Lin X, Zhang C, Wang L, Duara R, Wu Y, Giannini A, Bai G, Cai J, Greig M, Schofield E, Ashok R, Small B, Potter H, ... Arendash GW, et al. High Blood caffeine levels in MCI linked to lack of progression to dementia. Journal of Alzheimer's Disease : Jad. 30: 559-72. PMID 22430531 DOI: 10.3233/Jad-2012-111781  0.44
2012 Mori T, Rezai-Zadeh K, Koyama N, Arendash GW, Yamaguchi H, Kakuda N, Horikoshi-Sakuraba Y, Tan J, Town T. Tannic acid is a natural β-secretase inhibitor that prevents cognitive impairment and mitigates Alzheimer-like pathology in transgenic mice. The Journal of Biological Chemistry. 287: 6912-27. PMID 22219198 DOI: 10.1074/Jbc.M111.294025  0.44
2011 Zeitlin R, Patel S, Burgess S, Arendash GW, Echeverria V. Caffeine induces beneficial changes in PKA signaling and JNK and ERK activities in the striatum and cortex of Alzheimer's transgenic mice. Brain Research. 1417: 127-36. PMID 21907331 DOI: 10.1016/J.Brainres.2011.08.036  0.32
2011 Dragicevic N, Bradshaw PC, Mamcarz M, Lin X, Wang L, Cao C, Arendash GW. Long-term electromagnetic field treatment enhances brain mitochondrial function of both Alzheimer's transgenic mice and normal mice: A mechanism for electromagnetic field-induced cognitive benefit? Neuroscience. 185: 135-149. PMID 21514369 DOI: 10.1016/J.Neuroscience.2011.04.012  0.44
2011 Dragicevic N, Copes N, O'Neal-Moffitt G, Jin J, Buzzeo R, Mamcarz M, Tan J, Cao C, Olcese JM, Arendash GW, Bradshaw PC. Melatonin treatment restores mitochondrial function in Alzheimer's mice: a mitochondrial protective role of melatonin membrane receptor signaling. Journal of Pineal Research. 51: 75-86. PMID 21355879 DOI: 10.1111/J.1600-079X.2011.00864.X  0.44
2011 Echeverria V, Zeitlin R, Burgess S, Patel S, Barman A, Thakur G, Mamcarz M, Wang L, Sattelle DB, Kirschner DA, Mori T, Leblanc RM, Prabhakar R, Arendash GW. Cotinine reduces amyloid-β aggregation and improves memory in Alzheimer's disease mice. Journal of Alzheimer's Disease : Jad. 24: 817-35. PMID 21321389 DOI: 10.3233/Jad-2011-102136  0.44
2010 Casadesus G, Arendash G, Laferla F, McDonald M. Animal models of Alzheimer's disease. International Journal of Alzheimer's Disease. 2010: 606357. PMID 21804934 DOI: 10.4061/2010/606357  0.44
2010 Boyd TD, Bennett SP, Mori T, Governatori N, Runfeldt M, Norden M, Padmanabhan J, Neame P, Wefes I, Sanchez-Ramos J, Arendash GW, Potter H. GM-CSF upregulated in rheumatoid arthritis reverses cognitive impairment and amyloidosis in Alzheimer mice. Journal of Alzheimer's Disease : Jad. 21: 507-18. PMID 20555144 DOI: 10.3233/Jad-2010-091471  0.44
2010 Dragicevic N, Mamcarz M, Zhu Y, Buzzeo R, Tan J, Arendash GW, Bradshaw PC. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice. Journal of Alzheimer's Disease : Jad. 20: S535-50. PMID 20463404 DOI: 10.3233/Jad-2010-100342  0.44
2010 Arendash GW, Cao C. Caffeine and coffee as therapeutics against Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 20: S117-26. PMID 20182037 DOI: 10.3233/Jad-2010-091249  0.44
2010 Arendash GW, Sanchez-Ramos J, Mori T, Mamcarz M, Lin X, Runfeldt M, Wang L, Zhang G, Sava V, Tan J, Cao C. Electromagnetic field treatment protects against and reverses cognitive impairment in Alzheimer's disease mice. Journal of Alzheimer's Disease : Jad. 19: 191-210. PMID 20061638 DOI: 10.3233/Jad-2010-1228  0.44
2010 Mori T, Koyama N, Arendash GW, Horikoshi-Sakuraba Y, Tan J, Town T. Overexpression of human S100B exacerbates cerebral amyloidosis and gliosis in the Tg2576 mouse model of Alzheimer's disease. Glia. 58: 300-14. PMID 19705461 DOI: 10.1002/Glia.20924  0.44
2010 Echeverria V, Burgess S, Zeitlin R, Barman A, Thakur G, Inouye H, Feris E, Buckingham S, Kirschner D, Mori T, Leblanc R, Prabhakar R, Sattelle D, Arendash G. P3-290: Cotinine: A dual-action drug with multiple benefits against Alzheimer's disease Alzheimer's & Dementia. 6: S536-S537. DOI: 10.1016/J.Jalz.2010.05.1790  0.44
2009 Cao C, Cirrito JR, Lin X, Wang L, Wang L, Verges DK, Dickson A, Mamcarz M, Zhang C, Mori T, Arendash GW, Holtzman DM, Potter H. Caffeine suppresses amyloid-beta levels in plasma and brain of Alzheimer's disease transgenic mice. Journal of Alzheimer's Disease : Jad. 17: 681-97. PMID 19581723 DOI: 10.3233/Jad-2009-1071  0.44
2009 Arendash GW, Mori T, Cao C, Mamcarz M, Runfeldt M, Dickson A, Rezai-Zadeh K, Tane J, Citron BA, Lin X, Echeverria V, Potter H. Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer's disease mice. Journal of Alzheimer's Disease : Jad. 17: 661-80. PMID 19581722 DOI: 10.3233/Jad-2009-1087  0.44
2009 Arendash GW, Cox AA, Mori T, Cracchiolo JR, Hensley KL, Roberts LJ. Oxygen treatment triggers cognitive impairment in Alzheimer's transgenic mice. Neuroreport. 20: 1087-92. PMID 19543132 DOI: 10.1097/Wnr.0B013E32832E6459  0.44
2009 Olcese JM, Cao C, Mori T, Mamcarz MB, Maxwell A, Runfeldt MJ, Wang L, Zhang C, Lin X, Zhang G, Arendash GW. Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease. Journal of Pineal Research. 47: 82-96. PMID 19538338 DOI: 10.1111/J.1600-079X.2009.00692.X  0.44
2009 Sanchez-Ramos J, Song S, Sava V, Catlow B, Lin X, Mori T, Cao C, Arendash GW. Granulocyte colony stimulating factor decreases brain amyloid burden and reverses cognitive impairment in Alzheimer's mice. Neuroscience. 163: 55-72. PMID 19500657 DOI: 10.1016/J.Neuroscience.2009.05.071  0.44
2009 Echeverria V, Burgess S, Gamble-George J, Zeitlin R, Lin X, Cao C, Arendash GW. Sorafenib inhibits nuclear factor kappa B, decreases inducible nitric oxide synthase and cyclooxygenase-2 expression, and restores working memory in APPswe mice. Neuroscience. 162: 1220-31. PMID 19447162 DOI: 10.1016/J.Neuroscience.2009.05.019  0.44
2009 Cao C, Arendash GW, Dickson A, Mamcarz MB, Lin X, Ethell DW. Abeta-specific Th2 cells provide cognitive and pathological benefits to Alzheimer's mice without infiltrating the CNS. Neurobiology of Disease. 34: 63-70. PMID 19167499 DOI: 10.1016/J.Nbd.2008.12.015  0.44
2009 Catlow BJ, Rowe AR, Clearwater CR, Mamcarz M, Arendash GW, Sanchez-Ramos J. Effects of environmental enrichment and physical activity on neurogenesis in transgenic PS1/APP mice. Brain Research. 1256: 173-9. PMID 19135431 DOI: 10.1016/J.Brainres.2008.12.028  0.44
2009 Arendash GW. Response to commentary Journal of Alzheimer's Disease. 17: 701-702. DOI: 10.3233/JAD-2009-1086  0.44
2008 Echeverria V, Burgess S, Gamble-George J, Arendash GW, Citron BA. Raf inhibition protects cortical cells against beta-amyloid toxicity. Neuroscience Letters. 444: 92-6. PMID 18706973 DOI: 10.1016/J.Neulet.2008.07.092  0.32
2008 Cao C, Lin X, Zhang C, Wahi MM, Wefes I, Arendash G, Potter H. Mutant amyloid-beta-sensitized dendritic cells as Alzheimer's disease vaccine. Journal of Neuroimmunology. 200: 1-10. PMID 18649951 DOI: 10.1016/J.Jneuroim.2008.05.017  0.44
2008 Rezai-Zadeh K, Arendash GW, Hou H, Fernandez F, Jensen M, Runfeldt M, Shytle RD, Tan J. Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice. Brain Research. 1214: 177-87. PMID 18457818 DOI: 10.1016/J.Brainres.2008.02.107  0.44
2008 Mori T, Tan J, Arendash GW, Koyama N, Nojima Y, Town T. Overexpression of human S100B exacerbates brain damage and periinfarct gliosis after permanent focal ischemia. Stroke; a Journal of Cerebral Circulation. 39: 2114-21. PMID 18451356 DOI: 10.1161/Strokeaha.107.503821  0.44
2008 Leighty RE, Runfeldt MJ, Berndt DJ, Schleif WS, Cracchiolo JR, Potter H, Arendash GW. Use of artificial neural networks to determine cognitive impairment and therapeutic effectiveness in Alzheimer's transgenic mice. Journal of Neuroscience Methods. 167: 358-66. PMID 17904642 DOI: 10.1016/J.Jneumeth.2007.08.008  0.44
2007 Arendash GW, Jensen MT, Salem N, Hussein N, Cracchiolo J, Dickson A, Leighty R, Potter H. A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice. Neuroscience. 149: 286-302. PMID 17904756 DOI: 10.1016/J.Neuroscience.2007.08.018  0.44
2007 Cracchiolo JR, Mori T, Nazian SJ, Tan J, Potter H, Arendash GW. Enhanced cognitive activity--over and above social or physical activity--is required to protect Alzheimer's mice against cognitive impairment, reduce Abeta deposition, and increase synaptic immunoreactivity. Neurobiology of Learning and Memory. 88: 277-94. PMID 17714960 DOI: 10.1016/J.Nlm.2007.07.007  0.44
2007 Suo Z, Cox AA, Bartelli N, Rasul I, Festoff BW, Premont RT, Arendash GW. GRK5 deficiency leads to early Alzheimer-like pathology and working memory impairment. Neurobiology of Aging. 28: 1873-88. PMID 17011668 DOI: 10.1016/J.Neurobiolaging.2006.08.013  0.44
2007 Costa DA, Cracchiolo JR, Bachstetter AD, Hughes TF, Bales KR, Paul SM, Mervis RF, Arendash GW, Potter H. Enrichment improves cognition in AD mice by amyloid-related and unrelated mechanisms. Neurobiology of Aging. 28: 831-44. PMID 16730391 DOI: 10.1016/J.Neurobiolaging.2006.04.009  0.44
2006 Arendash GW, Schleif W, Rezai-Zadeh K, Jackson EK, Zacharia LC, Cracchiolo JR, Shippy D, Tan J. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production. Neuroscience. 142: 941-52. PMID 16938404 DOI: 10.1016/J.Neuroscience.2006.07.021  0.44
2006 Ethell DW, Shippy D, Cao C, Cracchiolo JR, Runfeldt M, Blake B, Arendash GW. Abeta-specific T-cells reverse cognitive decline and synaptic loss in Alzheimer's mice. Neurobiology of Disease. 23: 351-61. PMID 16733088 DOI: 10.1016/J.Nbd.2006.03.008  0.44
2006 Obregon DF, Rezai-Zadeh K, Bai Y, Sun N, Hou H, Ehrhart J, Zeng J, Mori T, Arendash GW, Shytle D, Town T, Tan J. ADAM10 activation is required for green tea (-)-epigallocatechin-3-gallate-induced alpha-secretase cleavage of amyloid precursor protein. The Journal of Biological Chemistry. 281: 16419-27. PMID 16624814 DOI: 10.1074/Jbc.M600617200  0.44
2005 Jensen MT, Mottin MD, Cracchiolo JR, Leighty RE, Arendash GW. Lifelong immunization with human beta-amyloid (1-42) protects Alzheimer's transgenic mice against cognitive impairment throughout aging. Neuroscience. 130: 667-84. PMID 15590151 DOI: 10.1016/J.Neuroscience.2004.09.055  0.44
2004 Bjugstad KB, Flitter WD, Arendash GW. Intracerebroventricular infusions of gp120 inhibit weight gain and induce atrophy in the hippocampus and neostriatum without affecting cognition. Journal of Neuro-Aids. 2: 15-31. PMID 16873203 DOI: 10.1300/J128v02n04_02  0.44
2004 Nilsson LN, Arendash GW, Leighty RE, Costa DA, Low MA, Garcia MF, Cracciolo JR, Rojiani A, Wu X, Bales KR, Paul SM, Potter H. Cognitive impairment in PDAPP mice depends on ApoE and ACT-catalyzed amyloid formation. Neurobiology of Aging. 25: 1153-67. PMID 15312961 DOI: 10.1016/J.Neurobiolaging.2003.12.011  0.44
2004 Arendash GW, Garcia MF, Costa DA, Cracchiolo JR, Wefes IM, Potter H. Environmental enrichment improves cognition in aged Alzheimer's transgenic mice despite stable beta-amyloid deposition. Neuroreport. 15: 1751-4. PMID 15257141 DOI: 10.1097/01.Wnr.0000137183.68847.4E  0.44
2004 Leighty RE, Nilsson LN, Potter H, Costa DA, Low MA, Bales KR, Paul SM, Arendash GW. Use of multimetric statistical analysis to characterize and discriminate between the performance of four Alzheimer's transgenic mouse lines differing in Abeta deposition. Behavioural Brain Research. 153: 107-21. PMID 15219712 DOI: 10.1016/J.Bbr.2003.11.004  0.44
2004 Arendash GW, Lewis J, Leighty RE, McGowan E, Cracchiolo JR, Hutton M, Garcia MF. Multi-metric behavioral comparison of APPsw and P301L models for Alzheimer's disease: linkage of poorer cognitive performance to tau pathology in forebrain. Brain Research. 1012: 29-41. PMID 15158158 DOI: 10.1016/J.Brainres.2004.02.081  0.44
2004 Garcia MF, Gordon MN, Hutton M, Lewis J, McGowan E, Dickey CA, Morgan D, Arendash GW. The retinal degeneration (rd) gene seriously impairs spatial cognitive performance in normal and Alzheimer's transgenic mice. Neuroreport. 15: 73-7. PMID 15106834 DOI: 10.1097/00001756-200401190-00015  0.44
2003 Austin L, Arendash GW, Gordon MN, Diamond DM, DiCarlo G, Dickey C, Ugen K, Morgan D. Short-term beta-amyloid vaccinations do not improve cognitive performance in cognitively impaired APP + PS1 mice. Behavioral Neuroscience. 117: 478-84. PMID 12802876 DOI: 10.1037/0735-7044.117.3.478  0.44
2003 Joseph JA, Denisova NA, Arendash G, Gordon M, Diamond D, Shukitt-Hale B, Morgan D. Blueberry supplementation enhances signaling and prevents behavioral deficits in an Alzheimer disease model. Nutritional Neuroscience. 6: 153-62. PMID 12793519 DOI: 10.1080/1028415031000111282  0.44
2002 Newman MB, Arendash GW, Shytle RD, Bickford PC, Tighe T, Sanberg PR. Nicotine's oxidative and antioxidant properties in CNS. Life Sciences. 71: 2807-20. PMID 12377264 DOI: 10.1016/S0024-3205(02)02135-5  0.44
2002 Arendash GW, King DL. Intra- and intertask relationships in a behavioral test battery given to Tg2576 transgenic mice and controls. Physiology & Behavior. 75: 643-52. PMID 12020729 DOI: 10.1016/S0031-9384(02)00640-6  0.44
2002 King DL, Arendash GW. Behavioral characterization of the Tg2576 transgenic model of Alzheimer's disease through 19 months. Physiology & Behavior. 75: 627-42. PMID 12020728 DOI: 10.1016/S0031-9384(02)00639-X  0.44
2002 King DL, Arendash GW. Maintained synaptophysin immunoreactivity in Tg2576 transgenic mice during aging: correlations with cognitive impairment. Brain Research. 926: 58-68. PMID 11814407 DOI: 10.1016/S0006-8993(01)03294-2  0.44
2001 Arendash GW, Gordon MN, Diamond DM, Austin LA, Hatcher JM, Jantzen P, DiCarlo G, Wilcock D, Morgan D. Behavioral assessment of Alzheimer's transgenic mice following long-term Abeta vaccination: task specificity and correlations between Abeta deposition and spatial memory. Dna and Cell Biology. 20: 737-44. PMID 11788052 DOI: 10.1089/10445490152717604  0.44
2001 Gordon MN, King DL, Diamond DM, Jantzen PT, Boyett KV, Hope CE, Hatcher JM, DiCarlo G, Gottschall WP, Morgan D, Arendash GW. Correlation between cognitive deficits and Abeta deposits in transgenic APP+PS1 mice. Neurobiology of Aging. 22: 377-85. PMID 11378242 DOI: 10.1016/S0197-4580(00)00249-9  0.44
2001 Arendash GW, King DL, Gordon MN, Morgan D, Hatcher JM, Hope CE, Diamond DM. Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes. Brain Research. 891: 42-53. PMID 11164808 DOI: 10.1016/S0006-8993(00)03186-3  0.44
2000 Bjugstad KB, Flitter WD, Garland WA, Philpot RM, Kirstein CL, Arendash GW. CPI-1189 prevents apoptosis and reduces glial fibrillary acidic protein immunostaining in a TNF-alpha infusion model for AIDS dementia complex. Journal of Neurovirology. 6: 478-91. PMID 11175320 DOI: 10.3109/13550280009091948  0.44
2000 Morgan D, Diamond DM, Gottschall PE, Ugen KE, Dickey C, Hardy J, Duff K, Jantzen P, DiCarlo G, Wilcock D, Connor K, Hatcher J, Hope C, Gordon M, Arendash GW. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature. 408: 982-5. PMID 11140686 DOI: 10.1038/35050116  0.44
1999 King DL, Arendash GW, Crawford F, Sterk T, Menendez J, Mullan MJ. Progressive and gender-dependent cognitive impairment in the APP(SW) transgenic mouse model for Alzheimer's disease. Behavioural Brain Research. 103: 145-62. PMID 10513583 DOI: 10.1016/S0166-4328(99)00037-6  0.44
1999 Arendash GW, Su GC, Crawford FC, Bjugstad KB, Mullan M. Intravascular beta-amyloid infusion increases blood pressure: implications for a vasoactive role of beta-amyloid in the pathogenesis of Alzheimer's disease. Neuroscience Letters. 268: 17-20. PMID 10400067 DOI: 10.1016/S0304-3940(99)00239-6  0.44
1999 Linert W, Bridge MH, Huber M, Bjugstad KB, Grossman S, Arendash GW. In vitro and in vivo studies investigating possible antioxidant actions of nicotine: relevance to Parkinson's and Alzheimer's diseases. Biochimica Et Biophysica Acta. 1454: 143-52. PMID 10381559 DOI: 10.1016/S0925-4439(99)00029-0  0.44
1999 Pompl PN, Mullan MJ, Bjugstad K, Arendash GW. Adaptation of the circular platform spatial memory task for mice: use in detecting cognitive impairment in the APP(SW) transgenic mouse model for Alzheimer's disease. Journal of Neuroscience Methods. 87: 87-95. PMID 10065997 DOI: 10.1016/S0165-0270(98)00169-1  0.44
1999 Socci DJ, Bjugstad KB, Jones HC, Pattisapu JV, Arendash GW. Evidence that oxidative stress is associated with the pathophysiology of inherited hydrocephalus in the H-Tx rat model. Experimental Neurology. 155: 109-17. PMID 9918710 DOI: 10.1006/Exnr.1998.6969  0.44
1999 Su GC, Arendash GW, Kalaria RN, Bjugstad KB, Mullan M. Intravascular infusions of soluble beta-amyloid compromise the blood-brain barrier, activate CNS glial cells and induce peripheral hemorrhage. Brain Research. 818: 105-17. PMID 9914443 DOI: 10.1016/S0006-8993(98)01143-3  0.44
1998 Bjugstad KB, Flitter WD, Garland WA, Su GC, Arendash GW. Preventive actions of a synthetic antioxidant in a novel animal model of AIDS dementia Brain Research. 795: 349-357. PMID 9622673 DOI: 10.1016/S0006-8993(98)00351-5  0.44
1997 Sengstock GJ, Zawia NH, Olanow CW, Dunn AJ, Arendash GW. Intranigral iron infusion in the rat - Acute elevations in nigral lipid peroxidation and striatal dopaminergic markers with ensuing nigral degeneration Biological Trace Element Research. 58: 177-195. PMID 9403131 DOI: 10.1007/Bf02917470  0.44
1997 Su GC, Arendash GW, Kalaria RN, Mullan MJ. Long-term venous A beta 1-40 infusion in rats causes lung hemorrhage and brain perivascular gliosis. Annals of the New York Academy of Sciences. 826: 440-6. PMID 9329720 DOI: 10.1111/J.1749-6632.1997.Tb48500.X  0.44
1997 Crawford F, Suo Z, Fang C, Sawar A, Su G, Arendash G, Mullan M. The vasoactivity of A beta peptides. Annals of the New York Academy of Sciences. 826: 35-46. PMID 9329679 DOI: 10.1111/J.1749-6632.1997.Tb48459.X  0.44
1996 Borlongan CV, Bjugstad KB, Stahl CE, Ross SD, Arendash GW, Cahill DW, Sanberg PR. Age-dependent neurobehavioral responses by young and mature adult rats to systemic kainic acid. Restorative Neurology and Neuroscience. 10: 103-8. PMID 21551859 DOI: 10.3233/Rnn-1996-10206  0.44
1996 Socci DJ, Arendash GW. Chronic nicotine treatment prevents neuronal loss in neocortex resulting from nucleus basalis lesions in young adult and aged rats Molecular and Chemical Neuropathology. 27: 285-305. PMID 9147414 DOI: 10.1007/Bf02815110  0.44
1996 Sack CA, Socci DJ, Crandall BM, Arendash GW. Antioxidant treatment with phenyl-α-tert-butyl nitrone (PBN) improves the cognitive performance and survival of aging rats Neuroscience Letters. 205: 181-184. PMID 8852588 DOI: 10.1016/0304-3940(96)12417-4  0.44
1996 Socci DJ, Pert CB, Ruff MR, Arendash GW. Peptide T prevents NBM lesion-induced cortical atrophy in aged rats. Peptides. 17: 831-7. PMID 8844774 DOI: 10.1016/0196-9781(96)00106-4  0.44
1996 Bjugstad KB, Mahnir VM, Kem WR, Socci DJ, Arendash GW. Long-term treatment with GTS-21 or nicotine enhances water maze performance in aged rats without affecting the density of nicotinic receptor subtypes in neocortex Drug Development Research. 39: 19-28. DOI: 10.1002/(Sici)1098-2299(19960901)39:1<19::Aid-Ddr3>3.0.Co;2-N  0.44
1995 Socci DJ, Crandall BM, Arendash GW. Chronic antioxidant treatment improves the cognitive performance of aged rats Brain Research. 693: 88-94. PMID 8653426 DOI: 10.1016/0006-8993(95)00707-W  0.44
1995 Socci DJ, Sanberg PR, Arendash GW. Nicotine enhances morris water maze performance of young and aged rats Neurobiology of Aging. 16: 857-860. PMID 8532124 DOI: 10.1016/0197-4580(95)00091-R  0.44
1995 Arendash GW, Sengstock GJ, Sanberg PR, Kem WR. Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21. Brain Research. 674: 252-9. PMID 7796104 DOI: 10.1016/0006-8993(94)01449-R  0.44
1995 Sastry S, Arendash GW. Time-dependent changes in iron levels and associated neuronal loss within the substantia nigra following lesions within the neostriatum/globus pallidus complex Neuroscience. 67: 649-666. PMID 7545796 DOI: 10.1016/0306-4522(94)00618-F  0.44
1994 Olanow CW, Arendash GW. Metals and free radicals in neurodegeneration Current Opinion in Neurology. 7: 548-558. PMID 7866588  0.44
1994 Oestreicher E, Sengstock GJ, Riederer P, Olanow CW, Dunn AJ, Arendash GW. Degeneration of nigrostriatal dopaminergic neurons increases iron within the substantia nigra: a histochemical and neurochemical study Brain Research. 660: 8-18. PMID 7828004 DOI: 10.1016/0006-8993(94)90833-8  0.44
1994 Sengstock GJ, Olanow CW, Dunn AJ, Barone S, Arendash GW. Progressive Changes in Striatal Dopaminergic Markers, Nigral Volume, and Rotational Behavior Following Iron Infusion into the Rat Substantia Nigra Experimental Neurology. 130: 82-94. PMID 7529713 DOI: 10.1006/Exnr.1994.1187  0.44
1993 Smith DA, Clarke LP, Fiedler JA, Murtagh FR, Bonaroti EA, Sengstock GJ, Arendash GW. Use of a clinical MR scanner for imaging the rat brain Brain Research Bulletin. 31: 115-120. PMID 8453482 DOI: 10.1016/0361-9230(93)90017-6  0.44
1993 Sengstock GJ, Olanow CW, Menzies RA, Dunn AJ, Arendash GW. Infusion of iron into the rat substantia nigra: Nigral pathology and dose‐dependent loss of striatal dopaminergic markers Journal of Neuroscience Research. 35: 67-82. PMID 7685399 DOI: 10.1002/Jnr.490350109  0.44
1992 Sengstock GJ, Olanow CW, Dunn AJ, Arendash GW. Iron induces degeneration of nigrostriatal neurons Brain Research Bulletin. 28: 645-649. PMID 1617450 DOI: 10.1016/0361-9230(92)90118-H  0.44
1992 Sengstock GJ, Johnson KB, Jantzen PT, Meyer EM, Dunn AJ, Arendash GW. Nucleus basalis lesions in neonate rats induce a selective cortical cholinergic hypofunction and cognitive deficits during adulthood Experimental Brain Research. 90: 163-174. PMID 1521605 DOI: 10.1007/Bf00229268  0.44
1992 Zawia N, Arendash GW, Wecker L. Basal forebrain cholinergic neurons in aged rat brain are more susceptible to ibotenate-induced degeneration than neurons in young adult brain. Brain Research. 589: 333-7. PMID 1393599 DOI: 10.1016/0006-8993(92)91295-P  0.44
1991 Kott JN, Westrum LE, Ardizzoni SC, Arendash GW. Ultrastructural localization of gold particles within neural grafts labeled with gold-filled Sendai viral envelopes. Journal of Electron Microscopy Technique. 18: 197-202. PMID 1653311 DOI: 10.1002/Jemt.1060180216  0.44
1990 Millard WJ, Arendash GW, Dunn AJ, Meyer EM. Effects of nucleus basalis lesions on cerebral cortical concentrations of corticotropin-releasing hormone (CRH)-like immunoreactivity in the rat. Neuroscience Letters. 113: 233-9. PMID 2377321 DOI: 10.1016/0304-3940(90)90309-W  0.44
1990 Mouton PR, Arendash GW. Atrophy of cholinergic neurons within the rat nucleus basalis magnocellularis following intracortical AF64A infusion Neuroscience Letters. 111: 52-57. PMID 2336191 DOI: 10.1016/0304-3940(90)90343-8  0.44
1989 Mouton PR, Meyer EM, Arendash GW. Intracortical AF64A: Memory impairments and recovery from cholinergic hypofunction Pharmacology, Biochemistry and Behavior. 32: 841-848. PMID 2798533 DOI: 10.1016/0091-3057(89)90045-2  0.44
1989 Arendash GW, Millard WJ, Dawson R, Dunn AJ, Meyer EM. Different long-term effects of bilateral and unilateral nucleus basalis lesions on rat cerebral cortical neurotransmitter content. Neurochemical Research. 14: 1113-8. PMID 2574419 DOI: 10.1007/Bf00965617  0.44
1989 Raulli RE, Arendash G, Crews FT. Effects of nBM lesions on muscarinic-stimulation of phosphoinositide hydrolysis. Neurobiology of Aging. 10: 191-7. PMID 2542819 DOI: 10.1016/0197-4580(89)90030-4  0.44
1988 Mouton PR, Meyer EM, Dunn AJ, Millard W, Arendash GW. Induction of cortical cholinergic hypofunction and memory retention deficits through intracortical AF64A infusions Brain Research. 444: 104-118. PMID 3359282 DOI: 10.1016/0006-8993(88)90918-3  0.44
1988 Ardizzoni SC, Michaels A, Arendash GW. Labeling of neural cells by gold-filled Sendai virus envelopes before intracerebral transplantation Science. 239: 635-637. PMID 2829355 DOI: 10.1126/Science.2829355  0.44
1987 Meyer EM, Arendash GW, Judkins JH, Ying L, Wade C, Kem WR. Effects of nucleus basalis lesions on the muscarinic and nicotinic modulation of [3H]acetylcholine release in the rat cerebral cortex Journal of Neurochemistry. 49: 1758-1762. PMID 3681294 DOI: 10.1111/J.1471-4159.1987.Tb02433.X  0.44
1987 Arendash GW, Gorski RA. Testosterone-induced enhancement of male medial preoptic tissue transplant volume in female recipients: a possible neuronotrophic action. Brain Research. 431: 69-77. PMID 3620986 DOI: 10.1016/0165-3806(87)90196-9  0.44
1987 ARENDASH GW, MOUTON PR. Transplantation of Nucleus Basalis Magnocellularis Cholinergic Neurons into the Cholinergic‐depleted Cerebral Cortex: Morphological and Behavioral Effects Annals of the New York Academy of Sciences. 495: 431-443. PMID 3474954 DOI: 10.1111/J.1749-6632.1987.Tb23692.X  0.44
1987 Arendash GW, Millard WJ, Dunn AJ, Meyer EM. Long-term neuropathological and neurochemical effects of nucleus basalis lesions in the rat. Science (New York, N.Y.). 238: 952-6. PMID 2890210 DOI: 10.1126/Science.2890210  0.44
1986 Arendash GW, Leung PCK. Alleviation of estrogen-induced hyperprolactinemia through intracerebral transplantation of hypothalamic tissue containing dopaminergic neurons<sup>1</sup> Neuroendocrinology. 43: 359-367. PMID 3736784 DOI: 10.1159/000124551  0.44
1985 Arendash GW. Alleviation of estrogen-induced hyperprolactinemia by hypothalamic tissue transplants containing tuberoinfundibular dopaminergic neurons Fernstrom Foundation Series. 663-670.  0.44
1983 Arendash GW, Gorski RA. Effects of discrete lesions of the sexually dimorphic nucleus of the preoptic area or other medial preoptic regions on the sexual behavior of male rats. Brain Research Bulletin. 10: 147-54. PMID 6824962 DOI: 10.1016/0361-9230(83)90086-2  0.44
1983 Arendash GW, Gorski RA. Suppression of lordotic responsiveness in the female rat during mesencephalic electrical stimulation. Pharmacology, Biochemistry, and Behavior. 19: 351-7. PMID 6227018 DOI: 10.1016/0091-3057(83)90064-3  0.44
1982 Arendash GW, Gorski RA. Enhancement of sexual behavior in female rats by neonatal transplantation of brain tissue from males. Science (New York, N.Y.). 217: 1276-8. PMID 7112132 DOI: 10.1126/Science.7112132  0.44
1982 Leung PC, Arendash GW, Whitmoyer DI, Gorski RA, Sawyer CH. Differential effects of central adrenoceptor agonists on luteinizing hormone release. Neuroendocrinology. 34: 207-14. PMID 6280093 DOI: 10.1159/000123301  0.44
1981 Leung PC, Whitmoyer DI, Arendash GW, Sawyer CH. Effects of intraventricular norepinephrine on preoptic-anterior hypothalamic electrical activity in the freely-moving rat: modulation by ovarian steroid hormones. Brain Research. 226: 143-54. PMID 7028210 DOI: 10.1016/0006-8993(81)91089-1  0.44
1981 Leung PC, Arendash GW, Whitmoyer DI, Gorski RA, Sawyer CH. Electrical stimulation of mesencephalic noradrenergic pathway: effects on luteinizing hormone levels in blood of ovariectomized and ovariectomized, steroid-primed rats. Endocrinology. 109: 720-8. PMID 6114855 DOI: 10.1210/Endo-109-3-720  0.44
1981 Leung PCK, Arendash GW, Whitmoyer DI. Effects of intraventricular infusion of α- and β-adrenoceptor agonists on blood levels of luteinizing hormone (LH) in ovariectomized (OVX) and OVX steroid-primed rats Anatomical Record. 199.  0.44
1980 Leung PCK, Arendash GW, Gorski RA, Sawyer CH. Effect of mesencephalic electrical stimulation on blood luteinizing hormone (LH) levels in ovariectomized (OVX) and OVX, steroid-primed rats Biology of Reproduction. 22: No. 23.  0.44
1979 Arendash GW, Gallo RV. Regional differences in response to electrical stimulation within the medial preoptic-suprachiasmatic region on blood luteinizing hormone levels in ovariectomized and ovariectomized, estrogen-primed rats Endocrinology. 104: 333-343. PMID 446364  0.44
1979 Arendash GW, Gallo RV. Effect of lesions in the suprachiasmatic nucleus-retrochiasmatic area on the inhibition of pulsatile lh release induced by electrical stimulation of the midbrain dorsal raphe nucleus Neuroendocrinology. 28: 349-357. PMID 379679 DOI: 10.1159/000122883  0.44
1978 Arendash GW, Gallo RV. A characterization of the effects of pentobarbital on episodic LH release in ovariectomized rats Neuroendocrinology. 27: 204-215. PMID 732952  0.44
1978 Arendash GW, Gallo RV. Apomorphine-Induced Inhibition of Episodic LH Release in Ovariectomized Rats with Complete Hypothalamic Deafferentation Proceedings of the Society For Experimental Biology and Medicine. 159: 121-125. PMID 568794 DOI: 10.3181/00379727-159-40296  0.44
1978 Arendash GW, Gallo RV. Serotonin involvement in the inhibition of episodic luteinizing hormone release during electrical stimulation of the midbrain dorsal raphe nucleus in ovariectomized rats Endocrinology. 102: 1199-1206. PMID 154399  0.44
1977 Arendash GW, Gallo RV. Serotonin mediated inhibition of episodic LH release (ELHR) during electrical stimulation of the dorsal raphe nucleus (DRN) in ovariectomized rats Physiologist. 20: 3.  0.44
Show low-probability matches.